Cargando…
Expression of a Highly Antigenic and Native-Like Folded Extracellular Domain of the Human α1 Subunit of Muscle Nicotinic Acetylcholine Receptor, Suitable for Use in Antigen Specific Therapies for Myasthenia Gravis
We describe the expression of the extracellular domain of the human α1 nicotinic acetylcholine receptor (nAChR) in lepidopteran insect cells (i-α1-ECD) and its suitability for use in antigen-specific therapies for Myasthenia Gravis (MG). Compared to the previously expressed protein in P. pastoris (y...
Autores principales: | Niarchos, Athanasios, Zouridakis, Marios, Douris, Vassilis, Georgostathi, Assimina, Kalamida, Dimitra, Sotiriadis, Alexandros, Poulas, Konstantinos, Iatrou, Kostas, Tzartos, Socrates J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869910/ https://www.ncbi.nlm.nih.gov/pubmed/24376846 http://dx.doi.org/10.1371/journal.pone.0084791 |
Ejemplares similares
-
A Striational Muscle Antigen and Myasthenia Gravis-Associated
Thymomas Share an Acetylcholine-Receptor Epitope
por: Marx, Alexander, et al.
Publicado: (1992) -
Recent Advances in Genetic Predisposition of Myasthenia Gravis
por: Zagoriti, Zoi, et al.
Publicado: (2013) -
Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014) -
Genetics of Myasthenia Gravis: A Case-Control Association Study in the Hellenic Population
por: Zagoriti, Zoi, et al.
Publicado: (2012) -
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)